A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Baricitinib Impurity 38 - Request Quote

Picture of Baricitinib Impurity 38

Baricitinib Impurity 38

SZ CAT No:SZ-B038054
CAS No
NA
Mol.F.
C13H20ClN3OSi
Mol.Wt.
297.9
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Baricitinib Impurity 38 is chemically 4-Chloro-7-(2-(2-(trimethylsilyl)ethoxy)ethyl)-7H-pyrrolo[2,3-d]pyrimidine. Baricitinib Impurity 38 is supplied with detailed characterization data compliant with regulatory guideline. Baricitinib Impurity 38 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Baricitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Baricitinib Impurity 38

Purchase Baricitinib Impurity 38

Baricitinib Impurity 38 suppliers

Baricitinib Impurity 38 manufacturers

Baricitinib Impurity 38 price

Order Baricitinib Impurity 38

Enquire Baricitinib Impurity 38

Baricitinib Impurity 38 cost

Baricitinib Impurity 38 Supplier

Baricitinib Impurity 38 Distributor

Baricitinib Impurity 38 for Method Validation

Baricitinib Reference Standard

Baricitinib Impurity 38 for ANDA Filing

Baricitinib Impurity 38 for Forced Degradation Studies

Baricitinib Impurity 38 Identification Standards

Baricitinib Impurity 38 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,